{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T03:56:57Z","timestamp":1767671817214,"version":"3.48.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01995-3","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T06:23:28Z","timestamp":1766298208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Search for novel biomarkers of febrile neutropenia in hematological patients: an overview"],"prefix":"10.1007","volume":"26","author":[{"given":"Esa","family":"Jantunen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0690-9883","authenticated-orcid":false,"given":"Kari","family":"Pulkki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0271-4368","authenticated-orcid":false,"given":"Auni","family":"Juutilainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"issue":"3","key":"1995_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/10428190701809172","volume":"49","author":"S H\u00e4m\u00e4l\u00e4inen","year":"2008","unstructured":"H\u00e4m\u00e4l\u00e4inen S, Kuittinen T, Matinlauri I, et al. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences. Leukemia Lymphoma. 2008;49(3):495\u2013501. https:\/\/doi.org\/10.1080\/10428190701809172.","journal-title":"Leukemia Lymphoma"},{"issue":"4","key":"1995_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference: Crit Care Med. 2003;31(4):1250\u20136. https:\/\/doi.org\/10.1097\/01.CCM.0000050454.01978.3B.","journal-title":"Crit Care Med"},{"issue":"8","key":"1995_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762\u201374. https:\/\/doi.org\/10.1001\/jama.2016.0288.","journal-title":"JAMA"},{"issue":"8","key":"1995_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"11\u201312","key":"1995_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/23744235.2017.1347814","volume":"49","author":"A Kolonen","year":"2017","unstructured":"Kolonen A, Sinisalo M, Huttunen R, et al. Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study. Infect Dis. 2017;49(11\u201312):799\u2013808. https:\/\/doi.org\/10.1080\/23744235.2017.1347814.","journal-title":"Infect Dis"},{"issue":"1","key":"1995_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/00365540802454706","volume":"41","author":"S H\u00e4m\u00e4l\u00e4inen","year":"2009","unstructured":"H\u00e4m\u00e4l\u00e4inen S, Kuittinen T, Matinlauri I, et al. Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome. Scand J Infect Dis. 2009;41(1):14\u201320. https:\/\/doi.org\/10.1080\/00365540802454706.","journal-title":"Scand J Infect Dis"},{"issue":"6","key":"1995_CR7","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/trf.16424","volume":"61","author":"A Turunen","year":"2021","unstructured":"Turunen A, Silvennoinen R, Partanen A, et al. Autograft cellular composition and outcome in myeloma patients: results of the prospective multicenter GOA study. Transfusion. 2021;61(6):1830\u201344. https:\/\/doi.org\/10.1111\/trf.16424.","journal-title":"Transfusion"},{"issue":"9","key":"1995_CR8","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1080\/10428194.2020.1762879","volume":"61","author":"A Turunen","year":"2020","unstructured":"Turunen A, Valtola J, Partanen A, et al. Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study. Leuk Lymphoma. 2020;61(9):2082\u201392. https:\/\/doi.org\/10.1080\/10428194.2020.1762879.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"1995_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","volume":"148","author":"JA Hanley","year":"1983","unstructured":"Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839\u201343. https:\/\/doi.org\/10.1148\/radiology.148.3.6878708.","journal-title":"Radiology"},{"issue":"7","key":"1995_CR10","doi-asserted-by":"publisher","first-page":"e0127272","DOI":"10.1371\/journal.pone.0127272","volume":"10","author":"G Shan","year":"2015","unstructured":"Shan G. Improved confidence intervals for the Youden index. PLoS One. 2015;10(7):e0127272. https:\/\/doi.org\/10.1371\/journal.pone.0127272.","journal-title":"PLoS One"},{"issue":"6","key":"1995_CR11","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3760\/cma.j.issn.0366-6999.20123102","volume":"126","author":"DL Li","year":"2013","unstructured":"Li DL, Shen F, Yin Y, Peng JX, Chen PY. Weighted Youden index and its two-independent-sample comparison based on weighted sensitivity and specificity. Chin Med J (Engl). 2013;126(6):1150\u20134.","journal-title":"Chin Med J (Engl)"},{"issue":"12","key":"1995_CR12","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.febslet.2006.03.087","volume":"580","author":"H Roy","year":"2006","unstructured":"Roy H, Bhardwaj S, Yl\u00e4-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett. 2006;580(12):2879\u201387. https:\/\/doi.org\/10.1016\/j.febslet.2006.03.087.","journal-title":"FEBS Lett"},{"issue":"6","key":"1995_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.shk.0000190827.36406.6e","volume":"24","author":"P Pickkers","year":"2005","unstructured":"Pickkers P, Sprong T, van Eijk L, et al. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock. 2005;24(6):508\u201312. https:\/\/doi.org\/10.1097\/01.shk.0000190827.36406.6e.","journal-title":"Shock"},{"issue":"6","key":"1995_CR14","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1213\/ane.0b013e31816a643f","volume":"106","author":"S Karlsson","year":"2008","unstructured":"Karlsson S, Pettil\u00e4 V, Tenhunen J, et al. Vascular endothelial growth factor in severe sepsis and septic shock. Anesth Analg. 2008;106(6):1820\u20136. https:\/\/doi.org\/10.1213\/ane.0b013e31816a643f.","journal-title":"Anesth Analg"},{"issue":"3","key":"1995_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1600-0609.2009.01260.x","volume":"83","author":"S H\u00e4m\u00e4l\u00e4inen","year":"2009","unstructured":"H\u00e4m\u00e4l\u00e4inen S, Juutilainen A, Matinlauri I, et al. Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein. Eur J Haematol. 2009;83(3):251\u20137. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01260.x.","journal-title":"Eur J Haematol"},{"issue":"5","key":"1995_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJM199807303390507","volume":"339","author":"ER Levin","year":"1998","unstructured":"Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339(5):321\u20138. https:\/\/doi.org\/10.1056\/NEJM199807303390507.","journal-title":"N Engl J Med"},{"issue":"6","key":"1995_CR17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3109\/10428191003743478","volume":"51","author":"S H\u00e4m\u00e4l\u00e4inen","year":"2010","unstructured":"H\u00e4m\u00e4l\u00e4inen S, Juutilainen A, Kuittinen T, et al. Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein. Leuk Lymphoma. 2010;51(6):1040\u20136. https:\/\/doi.org\/10.3109\/10428191003743478.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1995_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.104.472050","volume":"112","author":"M Brueckmann","year":"2005","unstructured":"Brueckmann M, Huhle G, Lang S, et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation. 2005;112(4):527\u201334. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.472050.","journal-title":"Circulation"},{"issue":"5","key":"1995_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/01.CCM.0000261893.72811.0F","volume":"35","author":"M Varpula","year":"2007","unstructured":"Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettil\u00e4 V. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med. 2007;35(5):1277\u201383. https:\/\/doi.org\/10.1097\/01.CCM.0000261893.72811.0F.","journal-title":"Crit Care Med"},{"issue":"5","key":"1995_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s12185-024-03896-9","volume":"121","author":"K Yamakawa","year":"2025","unstructured":"Yamakawa K, Okamoto K, Seki Y, et al. Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis. Int J Hematol. 2025;121(5):592\u2013604. https:\/\/doi.org\/10.1007\/s12185-024-03896-9.","journal-title":"Int J Hematol"},{"issue":"4","key":"1995_CR21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2478\/s11536-010-0012-y","volume":"5","author":"I Matinlauri","year":"2010","unstructured":"Matinlauri I, Juutilainen A, H\u00e4m\u00e4l\u00e4inen S, et al. Fibrinogen and antithrombin in hematological patients with neutropenic fever. Centr Eur J Med. 2010;5(4):520\u20136. https:\/\/doi.org\/10.2478\/s11536-010-0012-y.","journal-title":"Open Med"},{"issue":"2","key":"1995_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/00365540903338113","volume":"42","author":"A Juutilainen","year":"2010","unstructured":"Juutilainen A, H\u00e4m\u00e4l\u00e4inen S, Matinlauri I, et al. Serial plasma lactate measurements in haematological patients with neutropenic fever. Scand J Infect Dis. 2010;42(2):102\u20138. https:\/\/doi.org\/10.3109\/00365540903338113.","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"1995_CR23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00277-011-1211-6","volume":"90","author":"A Juutilainen","year":"2011","unstructured":"Juutilainen A, H\u00e4m\u00e4l\u00e4inen S, Niemenp\u00e4\u00e4 J, et al. Serum cortisol and inflammatory response in neutropenic fever. Ann Hematol. 2011;90(12):1467\u201375. https:\/\/doi.org\/10.1007\/s00277-011-1211-6.","journal-title":"Ann Hematol"},{"issue":"1","key":"1995_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","volume":"36","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296\u2013327. https:\/\/doi.org\/10.1097\/01.CCM.0000298158.12101.41.","journal-title":"Crit Care Med"},{"issue":"5","key":"1995_CR25","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, et al. 2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia. Crit Care Med. 2024;52(5):e219\u201333. https:\/\/doi.org\/10.1097\/CCM.0000000000006172.","journal-title":"Crit Care Med"},{"issue":"2","key":"1995_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","volume":"28","author":"NG Morgenthaler","year":"2007","unstructured":"Morgenthaler NG, M\u00fcller B, Struck J, et al. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock. 2007;28(2):219\u201326. https:\/\/doi.org\/10.1097\/SHK.0b013e318033e5da.","journal-title":"Shock"},{"issue":"1","key":"1995_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.peptides.2012.05.001","volume":"36","author":"AK Purhonen","year":"2012","unstructured":"Purhonen AK, V\u00e4nsk\u00e4 M, H\u00e4m\u00e4l\u00e4inen S, et al. Plasma copeptin in the assessment of febrile neutropenia. Peptides. 2012;36(1):129\u201332. https:\/\/doi.org\/10.1016\/j.peptides.2012.05.001.","journal-title":"Peptides"},{"issue":"2","key":"1995_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/CCM.0b013e3181957532","volume":"37","author":"S Jochberger","year":"2009","unstructured":"Jochberger S, D\u00f6rler J, Luckner G, et al. The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med. 2009;37(2):476\u201382. https:\/\/doi.org\/10.1097\/CCM.0b013e3181957532.","journal-title":"Crit Care Med"},{"issue":"1","key":"1995_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-007-9126-7","volume":"28","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol. 2008;28(1):1\u201313. https:\/\/doi.org\/10.1007\/s10875-007-9126-7.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1995_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jinf.2009.11.010","volume":"60","author":"MD de Kruif","year":"2010","unstructured":"de Kruif MD, Limper M, Sierhuis K, et al. PTX3 predicts severe disease in febrile patients at the emergency department. J Infect. 2010;60(2):122\u20137. https:\/\/doi.org\/10.1016\/j.jinf.2009.11.010.","journal-title":"J Infect"},{"issue":"1","key":"1995_CR31","doi-asserted-by":"publisher","first-page":"e53661","DOI":"10.1371\/journal.pone.0053661","volume":"8","author":"R Uusitalo-Sepp\u00e4l\u00e4","year":"2013","unstructured":"Uusitalo-Sepp\u00e4l\u00e4 R, Huttunen R, Aittoniemi J, et al. Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study. PLoS One. 2013;8(1):e53661. https:\/\/doi.org\/10.1371\/journal.pone.0053661.","journal-title":"PLoS One"},{"issue":"1","key":"1995_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/eci.12704","volume":"47","author":"P Caironi","year":"2017","unstructured":"Caironi P, Masson S, Mauri T, et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. Eur J Clin Invest. 2017;47(1):73\u201383. https:\/\/doi.org\/10.1111\/eci.12704.","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"1995_CR33","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3324\/haematol.2011.044925","volume":"96","author":"M V\u00e4nsk\u00e4","year":"2011","unstructured":"V\u00e4nsk\u00e4 M, Koivula I, H\u00e4m\u00e4l\u00e4inen S, et al. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients. Haematologica. 2011;96(9):1385\u20139. https:\/\/doi.org\/10.3324\/haematol.2011.044925.","journal-title":"Haematologica"},{"issue":"5","key":"1995_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1600-0609.2011.01666.x","volume":"87","author":"A Juutilainen","year":"2011","unstructured":"Juutilainen A, V\u00e4nsk\u00e4 M, Pulkki K, et al. Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy. Eur J Haematol. 2011;87(5):441\u20137. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01666.x.","journal-title":"Eur J Haematol"},{"issue":"6\u20137","key":"1995_CR35","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/00365548.2011.554855","volume":"43","author":"I Koivula","year":"2011","unstructured":"Koivula I, H\u00e4m\u00e4l\u00e4inen S, Jantunen E, et al. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia. Scand J Infect Dis. 2011;43(6\u20137):471\u20138. https:\/\/doi.org\/10.3109\/00365548.2011.554855.","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"1995_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cyto.2012.07.023","volume":"60","author":"M V\u00e4nsk\u00e4","year":"2012","unstructured":"V\u00e4nsk\u00e4 M, Koivula I, Jantunen E, et al. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients. Cytokine. 2012;60(3):787\u201392. https:\/\/doi.org\/10.1016\/j.cyto.2012.07.023.","journal-title":"Cytokine"},{"issue":"6","key":"1995_CR37","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/SHK.0000000000001678","volume":"55","author":"T Shimazui","year":"2021","unstructured":"Shimazui T, Nakada TA, Yazaki M, et al. Blood interleukin-6 levels predict multiple organ dysfunction in critically ill patients. Shock. 2021;55(6):790\u20135. https:\/\/doi.org\/10.1097\/SHK.0000000000001678.","journal-title":"Shock"},{"issue":"1","key":"1995_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2796.2011.02363.x","volume":"270","author":"R Huttunen","year":"2011","unstructured":"Huttunen R, Syrj\u00e4nen J, Vuento R, et al. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med. 2011;270(1):32\u201340. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02363.x.","journal-title":"J Intern Med"},{"key":"1995_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1741-7015-10-2","volume":"10","author":"K Donadello","year":"2012","unstructured":"Donadello K, Scolletta S, Covajes C, Vincent JL. SuPAR as a prognostic biomarker in sepsis. BMC Med. 2012;10:2. https:\/\/doi.org\/10.1186\/1741-7015-10-2.","journal-title":"BMC Med"},{"issue":"3","key":"1995_CR40","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3109\/10428194.2013.811582","volume":"55","author":"M V\u00e4nsk\u00e4","year":"2014","unstructured":"V\u00e4nsk\u00e4 M, Purhonen AK, Koivula I, et al. Soluble form of urokinase-type plasminogen activator receptor as a diagnostic and prognostic marker in hematological patients with neutropenic fever. Leuk Lymphoma. 2014;55(3):718\u201321. https:\/\/doi.org\/10.3109\/10428194.2013.811582.","journal-title":"Leuk Lymphoma"},{"key":"1995_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-019-0381-5","volume":"7","author":"H Gussen","year":"2019","unstructured":"Gussen H, Hohlstein P, Bartneck M, et al. Neutrophils are a main source of circulating suPAR predicting outcome in critical illness. J Intensive Care. 2019;7:26. https:\/\/doi.org\/10.1186\/s40560-019-0381-5.","journal-title":"J Intensive Care"},{"issue":"2","key":"1995_CR42","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/cc4894","volume":"10","author":"A Rhodes","year":"2006","unstructured":"Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care. 2006;10(2):R60. https:\/\/doi.org\/10.1186\/cc4894.","journal-title":"Crit Care"},{"issue":"6","key":"1995_CR43","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1373\/clinchem.2007.101030","volume":"54","author":"K Saukkonen","year":"2008","unstructured":"Saukkonen K, Lakkisto P, Pettil\u00e4 V, et al. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem. 2008;54(6):1000\u20137. https:\/\/doi.org\/10.1373\/clinchem.2007.101030.","journal-title":"Clin Chem"},{"issue":"4","key":"1995_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/00365548.2014.985711","volume":"47","author":"AK Purhonen","year":"2015","unstructured":"Purhonen AK, Juutilainen A, V\u00e4nsk\u00e4 M, et al. Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients. Infect Dis (Lond). 2015;47(4):255\u20139. https:\/\/doi.org\/10.3109\/00365548.2014.985711.","journal-title":"Infect Dis (Lond)"},{"issue":"4","key":"1995_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/SHK.0000000000000649","volume":"46","author":"KM Mortensen","year":"2016","unstructured":"Mortensen KM, Itenov TS, Haase N, et al. High levels of methylarginines were associated with increased mortality in patients with severe sepsis. Shock. 2016;46(4):365\u201372. https:\/\/doi.org\/10.1097\/SHK.0000000000000649.","journal-title":"Shock"},{"issue":"1","key":"1995_CR46","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13054-018-2090-1","volume":"22","author":"MS Winkler","year":"2018","unstructured":"Winkler MS, Nierhaus A, R\u00f6sler G, et al. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival. Crit Care. 2018;22(1):216. https:\/\/doi.org\/10.1186\/s13054-018-2090-1.","journal-title":"Crit Care"},{"issue":"2","key":"1995_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/00365513.2017.1286518","volume":"77","author":"M Lappalainen","year":"2017","unstructured":"Lappalainen M, H\u00e4m\u00e4l\u00e4inen S, Juutilainen A, et al. Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients. Scand J Clin Lab Invest. 2017;77(2):130\u20134. https:\/\/doi.org\/10.1080\/00365513.2017.1286518.","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"1995_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12871-016-0212-3","volume":"16","author":"X Liu","year":"2016","unstructured":"Liu X, Shen Y, Li Z, et al. Prognostic significance of APACHE II score and plasma SuPAR in Chinese patients with sepsis: a prospective observational study. BMC Anesthesiol. 2016;16(1):46. https:\/\/doi.org\/10.1186\/s12871-016-0212-3.","journal-title":"BMC Anesthesiol"},{"key":"1995_CR49","doi-asserted-by":"publisher","first-page":"1181697","DOI":"10.3389\/fimmu.2023.1181697","volume":"14","author":"H She","year":"2023","unstructured":"She H, Tan L, Wang Y, et al. Integrative single-cell RNA sequencing and metabolomics decipher the imbalanced lipid-metabolism in maladaptive immune responses during sepsis. Front Immunol. 2023;14:1181697. https:\/\/doi.org\/10.3389\/fimmu.2023.1181697.","journal-title":"Front Immunol"},{"issue":"1","key":"1995_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13054-023-04552-0","volume":"27","author":"Y Chang","year":"2023","unstructured":"Chang Y, Yoo HJ, Kim SJ, et al. A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes. Crit Care. 2023;27(1):263. https:\/\/doi.org\/10.1186\/s13054-023-04552-0.","journal-title":"Crit Care"},{"key":"1995_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6964529","volume":"2018","author":"M Lappalainen","year":"2018","unstructured":"Lappalainen M, Jokkala J, Juutilainen A, et al. Novel biomarker candidates for febrile neutropenia in hematological patients using nontargeted metabolomics. Dis Markers. 2018;2018:6964529. https:\/\/doi.org\/10.1155\/2018\/6964529.","journal-title":"Dis Markers"},{"issue":"2","key":"1995_CR52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s15010-015-0830-6","volume":"44","author":"ME Richter","year":"2016","unstructured":"Richter ME, Neugebauer S, Engelmann F, et al. Biomarker candidates for the detection of an infectious etiology of febrile neutropenia. Infection. 2016;44(2):175\u201386. https:\/\/doi.org\/10.1007\/s15010-015-0830-6.","journal-title":"Infection"},{"issue":"5","key":"1995_CR53","doi-asserted-by":"publisher","first-page":"e0197049","DOI":"10.1371\/journal.pone.0197049","volume":"13","author":"RS Kelly","year":"2018","unstructured":"Kelly RS, Lasky-Su J, Yeung SJ, et al. Integrative omics to detect bacteremia in patients with febrile neutropenia. PLoS ONE. 2018;13(5):e0197049. https:\/\/doi.org\/10.1371\/journal.pone.0197049.","journal-title":"PLoS ONE"},{"issue":"6","key":"1995_CR54","first-page":"715","volume":"24","author":"E Olad","year":"2014","unstructured":"Olad E, Sedighi I, Mehrvar A, et al. Presepsin (sCD14) as a marker of serious bacterial infections in chemotherapy induced severe neutropenia. Iran J Pediatr. 2014;24(6):715\u201322.","journal-title":"Iran J Pediatr"},{"key":"1995_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9805609","volume":"2017","author":"S Korpelainen","year":"2017","unstructured":"Korpelainen S, Intke C, H\u00e4m\u00e4l\u00e4inen S, et al. Soluble CD14 as a diagnostic and prognostic biomarker in hematological patients with febrile neutropenia. Dis Markers. 2017;2017:9805609. https:\/\/doi.org\/10.1155\/2017\/9805609.","journal-title":"Dis Markers"},{"issue":"6","key":"1995_CR56","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.090074","volume":"36","author":"M Mertens","year":"2009","unstructured":"Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol. 2009;36(6):1118\u201325. https:\/\/doi.org\/10.3899\/jrheum.090074.","journal-title":"J Rheumatol"},{"issue":"1","key":"1995_CR57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11739-024-03766-6","volume":"20","author":"B Kilic","year":"2025","unstructured":"Kilic B, Parlar K, Karup S, et al. Anakinra in the management of adult-onset Still\u2019s disease: a single-center experience. Intern Emerg Med. 2025;20(1):131\u20138. https:\/\/doi.org\/10.1007\/s11739-024-03766-6.","journal-title":"Intern Emerg Med"},{"issue":"7","key":"1995_CR58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jtct.2023.04.001","volume":"29","author":"N Gazeau","year":"2023","unstructured":"Gazeau N, Liang EC, Wu QV, et al. Anakinra for refractory cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy. Transpl Cell Ther. 2023;29(7):430\u20137. https:\/\/doi.org\/10.1016\/j.jtct.2023.04.001.","journal-title":"Transpl Cell Ther"},{"issue":"4","key":"1995_CR59","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1365-2141.1995.tb05398.x","volume":"91","author":"P Engervall","year":"1995","unstructured":"Engervall P, Andersson B, Bj\u00f6rkholm M. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol. 1995;91(4):838\u201345. https:\/\/doi.org\/10.1111\/j.1365-2141.1995.tb05398.x.","journal-title":"Br J Haematol"},{"issue":"4","key":"1995_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF01910312","volume":"71","author":"H Sch\u00f6nbohn","year":"1995","unstructured":"Sch\u00f6nbohn H, Schuler M, Kolbe K, et al. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann Hematol. 1995;71(4):161\u20138. https:\/\/doi.org\/10.1007\/BF01910312.","journal-title":"Ann Hematol"},{"key":"1995_CR61","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/ejh.13161","volume":"101","author":"C Intke","year":"2018","unstructured":"Intke C, Korpelainen S, H\u00e4m\u00e4l\u00e4inen S, et al. Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients. Eur J Haematol. 2018;101:691\u20138. https:\/\/doi.org\/10.1111\/ejh.13161.","journal-title":"Eur J Haematol"},{"issue":"3","key":"1995_CR62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12253-013-9733-y","volume":"20","author":"N Al-Dasooqi","year":"2014","unstructured":"Al-Dasooqi N, Wardill HR, Gibson RJ. Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury. Pathol Oncol Res. 2014;20(3):485\u201391. https:\/\/doi.org\/10.1007\/s12253-013-9733-y.","journal-title":"Pathol Oncol Res"},{"issue":"12","key":"1995_CR63","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1080\/10428194.2019.1617859","volume":"60","author":"S Becker","year":"2019","unstructured":"Becker S, Korpelainen S, Arvonen M, et al. MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia. Leuk Lymphoma. 2019;60(12):3036\u201343. https:\/\/doi.org\/10.1080\/10428194.2019.1617859.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1995_CR64","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1182\/blood.V92.4.1342","volume":"92","author":"L Guedez","year":"1998","unstructured":"Guedez L, Courtemanch L, Stetler-Stevenson M. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood. 1998;92(4):1342\u20139.","journal-title":"Blood"},{"issue":"4","key":"1995_CR65","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1213\/ANE.0000000000000120","volume":"118","author":"J H\u00e4stbacka","year":"2014","unstructured":"H\u00e4stbacka J, Linko R, Tervahartiala T, et al. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality. Anesth Analg. 2014;118(4):790\u20138. https:\/\/doi.org\/10.1213\/ANE.0000000000000120.","journal-title":"Anesth Analg"},{"issue":"1","key":"1995_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/SHK.0000000000001833","volume":"57","author":"TK Jones","year":"2022","unstructured":"Jones TK, Reilly JP, Anderson BJ, et al. Elevated plasma levels of matrix metalloproteinase-3 and tissue-inhibitor of matrix metalloproteinases-1 associate with organ dysfunction and mortality in sepsis. Shock. 2022;57(1):41\u20137. https:\/\/doi.org\/10.1097\/SHK.0000000000001833.","journal-title":"Shock"},{"key":"1995_CR67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cca.2015.12.009","volume":"453","author":"MV Eidt","year":"2016","unstructured":"Eidt MV, Nunes FB, Pedrazza L, et al. Biochemical and inflammatory aspects in patients with severe sepsis and septic shock: the predictive role of IL-18 in mortality. Clin Chim Acta. 2016;453:100\u20136. https:\/\/doi.org\/10.1016\/j.cca.2015.12.009.","journal-title":"Clin Chim Acta"},{"key":"1995_CR68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cyto.2019.04.003","volume":"120","author":"M Mierzchala-Pasierb","year":"2019","unstructured":"Mierzchala-Pasierb M, Krzystek-Korpacka M, Lesnik P, et al. Interleukin-18 serum levels in sepsis: correlation with disease severity and inflammatory markers. Cytokine. 2019;120:22\u20137. https:\/\/doi.org\/10.1016\/j.cyto.2019.04.003.","journal-title":"Cytokine"},{"key":"1995_CR69","doi-asserted-by":"publisher","first-page":"155021","DOI":"10.1016\/j.cyto.2020.155021","volume":"129","author":"S Korpelainen","year":"2020","unstructured":"Korpelainen S, H\u00e4m\u00e4l\u00e4inen S, V\u00e4nsk\u00e4 M, et al. Plasma level of interleukin-18 and complicated course of febrile neutropenia in hematological patients after intensive chemotherapy. Cytokine. 2020;129:155021. https:\/\/doi.org\/10.1016\/j.cyto.2020.155021.","journal-title":"Cytokine"},{"issue":"10","key":"1995_CR70","doi-asserted-by":"publisher","first-page":"e109618","DOI":"10.1371\/journal.pone.0109618","volume":"9","author":"L Lorente","year":"2014","unstructured":"Lorente L, Mart\u00edn MM, Gonz\u00e1lez-Rivero AF, et al. Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study. PLoS One. 2014;9(10):e109618. https:\/\/doi.org\/10.1371\/journal.pone.0109618.","journal-title":"PLoS One"},{"key":"1995_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8583121","volume":"2018","author":"A Koch","year":"2018","unstructured":"Koch A, Yagmur E, Linka J, et al. High circulating caspase-cleaved keratin 18 fragments (M30) indicate short-term mortality in critically ill patients. Dis Markers. 2018;2018:8583121. https:\/\/doi.org\/10.1155\/2018\/8583121.","journal-title":"Dis Markers"},{"issue":"1","key":"1995_CR72","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10238-021-00734-8","volume":"22","author":"C Intke","year":"2022","unstructured":"Intke C, Korpelainen S, Lappalainen M, et al. Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia. Clin Exp Med. 2022;22(1):83\u201393. https:\/\/doi.org\/10.1007\/s10238-021-00734-8.","journal-title":"Clin Exp Med"},{"issue":"2","key":"1995_CR73","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10495-016-1325-3","volume":"22","author":"T Girardot","year":"2017","unstructured":"Girardot T, Rimmel\u00e9 T, Venet F, Monneret G. Apoptosis-induced lymphopenia in sepsis and other severe injuries. Apoptosis. 2017;22(2):295\u2013305. https:\/\/doi.org\/10.1007\/s10495-016-1325-3.","journal-title":"Apoptosis"},{"issue":"1","key":"1995_CR74","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","volume":"24","author":"C Pierrakos","year":"2020","unstructured":"Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1):287. https:\/\/doi.org\/10.1186\/s13054-020-02993-5.","journal-title":"Crit Care"},{"key":"1995_CR75","doi-asserted-by":"publisher","first-page":"828569","DOI":"10.3389\/fped.2022.828569","volume":"10","author":"FJS van der Velden","year":"2022","unstructured":"van der Velden FJS, Gennery AR, Emonts M. Biomarkers for diagnosing febrile illness in immunocompromised children: a systematic review of the literature. Front Pediatr. 2022;10:828569. https:\/\/doi.org\/10.3389\/fped.2022.828569.","journal-title":"Front Pediatr"},{"issue":"3","key":"1995_CR76","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00134-006-0504-z","volume":"33","author":"S Karlsson","year":"2007","unstructured":"Karlsson S, Varpula M, Ruokonen E, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med. 2007;33(3):435\u201343. https:\/\/doi.org\/10.1007\/s00134-006-0504-z.","journal-title":"Intensive Care Med"},{"issue":"6","key":"1995_CR77","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/ejh.13500","volume":"105","author":"M Lappalainen","year":"2020","unstructured":"Lappalainen M, H\u00e4m\u00e4l\u00e4inen S, Romppanen T, et al. Febrile neutropenia in patients with acute myeloid leukemia: outcome in relation to qSOFA score, C-reactive protein, and blood culture findings. Eur J Haematol. 2020;105(6):731\u201340. https:\/\/doi.org\/10.1111\/ejh.13500.","journal-title":"Eur J Haematol"},{"issue":"4","key":"1995_CR78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/ejh.14264","volume":"113","author":"E Jantunen","year":"2024","unstructured":"Jantunen E, H\u00e4m\u00e4l\u00e4nen S, Pulkki K, Juutilainen A. Novel biomarkers to identify complicated course of febrile neutropenia in hematological patients receiving intensive chemotherapy. Eur J Haematol. 2024;113(4):392\u20139. https:\/\/doi.org\/10.1111\/ejh.14264.","journal-title":"Eur J Haematol"},{"issue":"6","key":"1995_CR79","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7861\/clinmedicine.12-6-501","volume":"12","author":"M Jones","year":"2012","unstructured":"Jones M. NEWSDIG: the National Early Warning Score Development and Implementation Group. Clin Med (Lond). 2012;12(6):501\u20133. https:\/\/doi.org\/10.7861\/clinmedicine.12-6-501.","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"1995_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211133","volume":"14","author":"A Brink","year":"2019","unstructured":"Brink A, Alsma J, Verdonschot R, et al. Predicting mortality in patients with suspected sepsis at the emergency department; a retrospective cohort study comparing qSOFA, SIRS and National Early Warning Score. PLoS One. 2019;14(1):e0211133. https:\/\/doi.org\/10.1371\/journal.pone.0211133.","journal-title":"PLoS One"},{"issue":"5","key":"1995_CR81","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s15010-024-02247-4","volume":"52","author":"L Boekhoud","year":"2024","unstructured":"Boekhoud L, Schaap H, Huizinga RL, et al. Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department. Infection. 2024;52(5):1863\u201373. https:\/\/doi.org\/10.1007\/s15010-024-02247-4.","journal-title":"Infection"},{"issue":"23","key":"1995_CR82","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015981","volume":"98","author":"H Yu","year":"2019","unstructured":"Yu H, Nie L, Liu A, et al. Combining procalcitonin with the qSOFA and sepsis mortality prediction. Medicine (Baltimore). 2019;98(23):e15981. https:\/\/doi.org\/10.1097\/MD.0000000000015981.","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"1995_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173869","volume":"10","author":"M Bolanaki","year":"2021","unstructured":"Bolanaki M, M\u00f6ckel M, Winning J, et al. Diagnostic performance of procalcitonin for the early identification of sepsis in patients with elevated qSOFA score at emergency admission. J Clin Med. 2021;10(17):3869. https:\/\/doi.org\/10.3390\/jcm10173869.","journal-title":"J Clin Med"},{"issue":"1","key":"1995_CR84","doi-asserted-by":"publisher","first-page":"16605","DOI":"10.1038\/s41598-020-73676-y","volume":"10","author":"S Spoto","year":"2020","unstructured":"Spoto S, Nobile E, Carn\u00e0 EPR, et al. Best diagnostic accuracy of sepsis combining SIRS criteria or qSOFA score with procalcitonin and mid-regional pro-adrenomedullin outside ICU. Sci Rep. 2020;10(1):16605. https:\/\/doi.org\/10.1038\/s41598-020-73676-y.","journal-title":"Sci Rep"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01995-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T03:52:12Z","timestamp":1767671532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01995-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1995"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01995-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was accepted by the Ethical Board of North Savo Hospital District in 2006 (100\/2006) with several subsequent amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/Consent"}}],"article-number":"83"}}